Literature DB >> 10912838

Walking after stroke: does it matter? Changes in bone mineral density within the first 12 months after stroke. A longitudinal study.

L Jørgensen1, B K Jacobsen, T Wilsgaard, J H Magnus.   

Abstract

Stroke patients have increased risk of hip fractures. Nearly all fractures occur on the hemiplegic side, and reduced bone mineral density (BMD) may be an important predisposing factor. The aim of this study was to investigate the degree of demineralization within the first year after stroke, and to elucidate a possible difference in patients with high versus low ambulatory levels. Forty acute stroke patients were followed (17 initially wheelchair-bound and 23 initially ambulatory). BMD was measured in the proximal femur bilaterally at a mean 6 days, 7 months and 1 year after stroke onset using dual-energy X-ray absorptiometry. Ambulatory status was independently associated with changes in BMD (p < or = 0.005) 1 year after stroke. The 17 initially wheelchair-bound patients had a significant 10% reduction in BMD at the paretic side and 5% reduction at the non-paretic side (p < 0.001), while the 23 patients initially able to walk had a significant loss (3%) only at the paretic side (p = 0.01). The analysis also indicated that the major reduction in BMD took place within the first 7 months. Two months after stroke 12 of the wheelchair-bound patients had relearned to walk. At the paretic side the 1 year changes in BMD in the patients who stayed wheelchair-bound, the patients who re-learned to walk within the first 2 months and the patients who were able to walk throughout the study were 13%, 8% and 3%, respectively, and a statistically significant trend with ambulatory level was found (p = 0.007). This study provides clear evidence that lack of mobility and weight-bearing early after stroke is an important factor for the greater bone loss in the paretic leg, but that relearning to walk within the first 2 months after stroke, even with the support of another person, may reduce the bone loss after immobilization.

Entities:  

Mesh:

Year:  2000        PMID: 10912838     DOI: 10.1007/s001980070103

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  37 in total

1.  Specialized connective tissue: bone, the structural framework of the upper extremity.

Authors:  Alyssa M Weatherholt; Robyn K Fuchs; Stuart J Warden
Journal:  J Hand Ther       Date:  2011-11-01       Impact factor: 1.950

2.  Fitness and Mobility Exercise (FAME) Program for stroke.

Authors:  Janice J Eng
Journal:  Top Geriatr Rehabil       Date:  2010

3.  A 19-week exercise program for people with chronic stroke enhances bone geometry at the tibia: a peripheral quantitative computed tomography study.

Authors:  M Y C Pang; M C Ashe; J J Eng; H A McKay; A S Dawson
Journal:  Osteoporos Int       Date:  2006-07-29       Impact factor: 4.507

4.  An assessment of the osteogenic index of therapeutic exercises for stroke patients: relationship to severity of leg motor impairment.

Authors:  R W K Lau; M Y C Pang
Journal:  Osteoporos Int       Date:  2008-10-23       Impact factor: 4.507

5.  Stroke in relation to use of raloxifene and other drugs against osteoporosis.

Authors:  P Vestergaard; K Schwartz; E M Pinholt; L Rejnmark; L Mosekilde
Journal:  Osteoporos Int       Date:  2010-05-07       Impact factor: 4.507

6.  Impact and risk factors of post-stroke bone fracture.

Authors:  Kang Huo; Syed I Hashim; Kimberley L Y Yong; Hua Su; Qiu-Min Qu
Journal:  World J Exp Med       Date:  2016-02-20

7.  Compromised bone strength index in the hemiparetic distal tibia epiphysis among chronic stroke patients: the association with cardiovascular function, muscle atrophy, mobility, and spasticity.

Authors:  M Y C Pang; M C Ashe; J J Eng
Journal:  Osteoporos Int       Date:  2009-10-31       Impact factor: 4.507

8.  Rapid long-term bone loss following stroke in a man with osteoporosis and atherosclerosis.

Authors:  Kenneth E S Poole; Elizabeth A Warburton; Jonathan Reeve
Journal:  Osteoporos Int       Date:  2004-06-10       Impact factor: 4.507

9.  Bone structure and remodelling in stroke patients: early effects of zoledronate.

Authors:  Kenneth E S Poole; Shobna Vedi; Irene Debiram; Collette Rose; Jon Power; Nigel Loveridge; Elizabeth A Warburton; Jonathan Reeve; Juliet Compston
Journal:  Bone       Date:  2008-12-11       Impact factor: 4.398

10.  The FLASSH study: protocol for a randomised controlled trial evaluating falls prevention after stroke and two sub-studies.

Authors:  Frances A Batchelor; Keith D Hill; Shylie F Mackintosh; Catherine M Said; Craig H Whitehead
Journal:  BMC Neurol       Date:  2009-03-31       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.